Is there an additional value of 11C-Choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 5, 2012, Pages 1486-1492

  Van Den Bergh, Laura ^a   Koole, Michel ^a   Isebaert, Sofie ^a   Joniau, Steven ^a   Deroose, Christophe M ^a   Oyen, Raymond ^a   Lerut, Evelyne ^a   Budiharto, Tom ^a   Mottaghy, Felix ^a,b   Bormans, Guy ^a   Van Poppel, Hendrik ^a   Haustermans, Karin ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

11C choline PET CT; Intraprostatic boost; Prostate cancer; T2 weighted MRI; Tumor localization

Indexed keywords

11C-CHOLINE PET-CT; COMPUTED TOMOGRAPHY; GLEASON SCORES; GOLD STANDARDS; INTRAPROSTATIC BOOST; MR IMAGES; MRI IMAGE; POSITIVE CORRELATIONS; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; RADICAL PROSTATECTOMY; RIGID REGISTRATION; STANDARDIZED UPTAKE VALUES; TUMOR LOCALIZATION; TUMOR VOLUMES;

DISEASES; MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; TUMORS; UROLOGY;

COMPUTERIZED TOMOGRAPHY;

CHOLINE C 11; IOPROMIDE; PROSTATE SPECIFIC ANTIGEN; CARBON; CHOLINE; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LYMPHADENECTOMY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; BIOPSY; CANCER GRADING; CANCER STAGING; COMPARATIVE STUDY; EVALUATION; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR; RECEIVER OPERATING CHARACTERISTIC; SCINTISCANNING;

AGED; BIOPSY; CARBON RADIOISOTOPES; CHOLINE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR BURDEN;

EID: 84863619327     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.10.046     Document Type: Article

References (28)

1. A. Al-Mamgani, W.L. van Putten, and W.D. Heemsbergen Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 72 2008 980 988
2. D.A. Kuban, S.L. Tucker, and L. Dong Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74
3. S.T. Peeters, W.D. Heemsbergen, and P.C. Koper Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized Phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996
4. N. Cellini, A.G. Morganti, and G.C. Mattiucci Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: Implications for conformal therapy planning Int J Radiat Oncol Biol Phys 53 2002 595 599
5. D. Pucar, H. Hricak, and A. Shukla-Dave Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: Magnetic resonance imaging and step-section pathology evidence Int J Radiat Oncol Biol Phys 69 2007 62 69
6. V. Fonteyne, G. Villeirs, and B. Speleers Intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion Int J Radiat Oncol Biol Phys 72 2008 799 807
7. B. Turkbey, P.A. Pinto, and P.L. Choyke Imaging techniques for prostate cancer: Implications for focal therapy Nat Rev Urol 6 2009 191 203
8. T. Hara, N. Kosaka, and H. Kishi PET imaging of prostate cancer using carbon-11-choline J Nucl Med 39 1998 990 995
9. M. Farsad, R. Schiavina, and P. Castellucci Detection and localization of prostate cancer: Correlation of (11)C-choline PET/CT with histopathologic step-section analysis J Nucl Med 46 2005 1642 1649
10. J. Kotzerke, J. Prang, and B. Neumaier Experience with carbon-11 choline positron emission tomography in prostate carcinoma Eur J Nucl Med 27 2000 1415 1419
11. M. Picchio, C. Messa, and C. Landoni Value of [11C]choline-positron emission tomography for re-staging prostate cancer: A comparison with [18F]fluorodeoxyglucose-positron emission tomography J Urol 169 2003 1337 1340
12. E. Sutinen, M. Nurmi, and A. Roivainen Kinetics of [(11)C]choline uptake in prostate cancer: A PET study Eur J Nucl Med Mol Imaging 31 2004 317 324
13. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era Cancer 95 2002 281 286
14. R. Montironi, T. van der Kwast, and L. Boccon-Gibod Handling and pathology reporting of radical prostatectomy specimens Eur Urol 44 2003 626 636
15. C.M. Hoeks, J.O. Barentsz, and T. Hambrock Prostate cancer: Multiparametric MR imaging for detection, localization, and staging Radiology 261 2011 46 66
16. F. Maes, A. Collignon, and D. Vandermeulen Multimodality image registration by maximization of mutual information IEEE Trans Med Imaging 16 1997 187 198
17. M. Debois, R. Oyen, and F. Maes The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer Int J Radiat Oncol Biol Phys 45 1999 857 865
18. N.B. Delongchamps, M. Rouanne, and T. Flam Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: Combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging BJU Int 107 2011 1411 1418
19. G. Giovacchini, M. Picchio, and E. Coradeschi [(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: Relation to PSA levels, tumour stage and anti-androgenic therapy Eur J Nucl Med Mol Imaging 35 2008 1065 1073
20. S.N. Reske, N.M. Blumstein, and B. Neumaier Imaging prostate cancer with 11C-choline PET/CT J Nucl Med 47 2006 1249 1254
21. B. Scher, M. Seitz, and W. Albinger Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer Eur J Nucl Med Mol Imaging 34 2007 45 53
22. C. Testa, R. Schiavina, and R. Lodi Prostate cancer: Sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT Radiology 244 2007 797 806
23. S.A. Kwee, H. Wei, and I. Sesterhenn Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET J Nucl Med 47 2006 262 269
24. M. Beheshti, L. Imamovic, and G. Broinger 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: A prospective study of 130 patients Radiology 254 2010 925 933
25. A.J. Breeuwsma, J. Pruim, and M.M. Jongen In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer Eur J Nucl Med Mol Imaging 32 2005 668 673
26. G. Groenendaal, M.R. Moman, and J.G. Korporaal Validation of functional imaging with pathology for tumor delineation in the prostate Radiother Oncol 94 2010 145 150
27. H. Park, M.R. Piert, and A. Khan Registration methodology for histological sections and in vivo imaging of human prostate Acad Radiol 15 2008 1027 1039
28. H. Park, C.R. Meyer, and D. Wood Validation of automatic target volume definition as demonstrated for 11C-choline PET/CT of human prostate cancer using multi-modality fusion techniques Acad Radiol 17 2010 614 623